Cereno Scientific releases Insights Video Season 3 Episode 8 with Dr. Björn Dahlöf, CSO, Cereno Scientific
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for common and rare cardiovascular disease, today announced that episode 8 of Season 3 in the Insights Video Series has been released. In the video, recorded at the Pulmonary Vascular Research Institute (PVRI) Annual Congress 2024, Cereno’s Chief Scientific Officer (CSO) Dr. Björn Dahlöf talks about what cardiovascular remodeling is and what it means for cardiovascular disease (CVD), the effect of HDAC inhibitors on structural cardiovascular remodeling and the implications of HDAC inhibition